New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
about
Granzyme B inhibits vaccinia virus production through proteolytic cleavage of eukaryotic initiation factor 4 gamma 3Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells.Regulatory T Cells: Molecular Actions on Effector Cells in Immune RegulationDefining the interaction of perforin with calcium and the phospholipid membraneStructural Basis for Ca2+-mediated Interaction of the Perforin C2 Domain with Lipid MembranesCytotoxic proteins and therapeutic targets in severe cutaneous adverse reactionsMcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cellsSerglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storageGranzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737Perforin-dependent nuclear targeting of granzymes: A central role in the nuclear events of granule-exocytosis-mediated apoptosis?Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin.EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A.Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.BCL-2 blocks perforin-induced nuclear translocation of granzymes concomitant with protection against the nuclear events of apoptosis.Definition and redesign of the extended substrate specificity of granzyme B.Regulation of pro-apoptotic leucocyte granule serine proteinases by intracellular serpins.Cell death induced by the Fas/Fas ligand pathway and its role in pathology.The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes.Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage.Granzyme A activates another way to diePerforin rapidly induces plasma membrane phospholipid flip-flopProfiling protein function with small molecule microarrays.Delivery and therapeutic potential of human granzyme B.Protocatechuic aldehyde inhibits lipopolysaccharide-induced human umbilical vein endothelial cell apoptosis via regulation of caspase-3.Effects of MACPF/CDC proteins on lipid membranes.Discordant regulation of granzyme H and granzyme B expression in human lymphocytes.Cell-mediated cytotoxicity in recovery from poxvirus infections.Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells.Perforin: structure, function, and role in human immunopathology.Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.Granzyme B: a natural born killer.Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropinPerforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption.Perforin activity at membranes leads to invaginations and vesicle formation.Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis.Perforin and lymphohistiocytic proliferative disorders.Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosisPerforin and Fas/FasL cytolytic pathways at the maternal-fetal interface.Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis.
P2860
Q21559400-2982B9AD-D349-4085-9239-687701A5F7E3Q24630734-643A890B-2EB9-4844-B350-E815836823CAQ26746113-F8FA1402-42D3-433C-96B9-5952EDF06C24Q27686809-6625DC8C-42F6-4AC1-9718-AE74D72CD3D3Q28266624-A072D9CA-6D8C-4B8C-813C-7D96E7BC7571Q28395744-144AC13D-1A77-471F-B397-B569D5B06188Q28473557-067972F5-2A31-4DB3-AB5D-EDFF16E54831Q28508375-F23C8A2E-0735-4A1F-A670-9540F3C845C2Q30523061-9ED36CFA-1094-419B-975A-4552F66F94F7Q30710689-3E80F64C-A8FE-4C77-9AE5-208040F93876Q30864967-215B69F5-CEEE-4092-B691-1E45CAAF8923Q31115054-E70A8C17-B41F-4E01-858A-958294262BD1Q31520093-87247C0A-2BC8-459F-BA2B-F4E5A0E81F98Q31909336-7D8617DE-8389-4C3E-808E-4DD61C76D43DQ31915818-F923213D-3D70-41DD-844D-3AB2F1801567Q32003176-1A7C51C3-BFFA-439F-B0D3-75A8ABDA4D59Q33547789-8D20EA5A-211C-4882-9875-AD2A57C1D9E0Q33717488-F4E8319E-D138-4C23-AE9E-0EB9DE92D425Q33876972-EEF0A76D-A506-4E2E-BFAB-143D1A012178Q33991174-9BC4966A-777B-416F-8BEF-0D038FBF3097Q34002316-C2E641D8-8013-4BB2-95F2-ED53DB6B4BC4Q34023350-BE07AC08-942C-4ABC-B52C-28E5C45A27C1Q34037176-C8F3ED9E-C80A-4D24-B02D-7086415E3E5BQ34120062-848724F3-9FAC-4D9D-877D-5DCDBDB108EDQ34148765-56937A83-8933-4A49-9ED4-9FF72700F3DCQ34300045-1A0475AF-CE6F-4853-824E-8C5B14B00A5FQ34311596-173714FA-2624-4C04-9E6E-A332EF29BC66Q34534717-E1483713-48CC-4C4F-A1BB-6BE111EC7F09Q34569924-4695E01E-F7F0-4AC9-8F1E-3810CFDD6022Q34620426-9BBC3AFF-15FE-4F25-934E-8916BD588C15Q35004399-6096D8DD-83FA-4BDE-AD64-2B6D30DD03AFQ35129699-EE0A331D-09DC-4849-962B-F4687FDA93C0Q35233582-6B518B85-EE43-49DA-BC36-E7B6F6099CB8Q35357969-98440849-94A8-477C-A9D9-54A92FEB6991Q35641456-332C5E1F-8E60-482D-A699-23C2B809E480Q35834606-02490359-3258-4AAE-A464-39CAD09C0E38Q36065181-46A933E2-7469-45FC-8248-6CA702C8FDDAQ36117770-E4894ADA-36C9-4F49-A77D-B7D15719C407Q36280438-B70C5C0C-17FF-4956-B207-2E6EE0A307CFQ36322609-06DCC2AB-FD6B-4273-B96D-29ED44D03643
P2860
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im November 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 1996
@uk
name
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
@en
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
@nl
type
label
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
@en
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
@nl
prefLabel
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
@en
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
@nl
P2093
P2860
P356
P1476
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
@en
P2093
Bernard Babior
Christopher J. Froelich
Girish M. Shah
Jane Turbov
R. Christopher Bleackley
Roberta Gottlieb
Vishva M. Dixit
William Hanna
P2860
P304
29073-29079
P356
10.1074/JBC.271.46.29073
P407
P50
P577
1996-11-15T00:00:00Z